(Q27002805)

language of work or name

1 reference

June 2014

1 reference

published in

Arthritis & Rheumatology

1 reference

volume

66

1 reference

issue

6

1 reference

page(s)

1405-13

1 reference

The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families

cites work

1 reference

Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes

21 January 2018

1 reference

Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study

21 January 2018

1 reference

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features

21 January 2018

1 reference

Care of the adult with juvenile rheumatoid arthritis

21 January 2018

1 reference

Adult outcomes of patients with juvenile idiopathic arthritis

21 January 2018

1 reference

Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series

21 January 2018

1 reference

Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort

21 January 2018

1 reference

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

21 January 2018

1 reference

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis

21 January 2018

1 reference

Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

21 January 2018

1 reference

Anakinra for systemic juvenile arthritis: the Rocky Mountain experience

21 January 2018

1 reference

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

21 January 2018

1 reference

Long-term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis.

21 January 2018

1 reference

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features.

21 January 2018

1 reference

Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

21 January 2018

1 reference

Biologic treatments for adult-onset Still's disease.

21 January 2018

1 reference

Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.

21 January 2018

1 reference

PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis

21 January 2018

1 reference

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition

21 January 2018

1 reference

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes

21 January 2018

1 reference

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

21 January 2018

1 reference

Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.

21 January 2018

1 reference

Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes.

21 January 2018

1 reference

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions

21 January 2018

1 reference

Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis

21 January 2018

1 reference

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

21 January 2018

1 reference

Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis

21 January 2018

1 reference

Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review

21 January 2018

1 reference

IL-1 pathways in inflammation and human diseases

21 January 2018

1 reference

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

21 January 2018

1 reference

The plasticity of human Treg and Th17 cells and its role in autoimmunity

21 January 2018

1 reference

Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.

21 January 2018

1 reference

Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis

21 January 2018

1 reference

The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease

21 January 2018

1 reference

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

21 January 2018

1 reference

Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis

21 January 2018

1 reference

Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1

21 January 2018

1 reference

The genetic and immunopathological processes underlying collagen-induced arthritis

21 January 2018

1 reference

Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells.

21 January 2018

1 reference

Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice

21 January 2018

1 reference

T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.

21 January 2018

1 reference

TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice

21 January 2018

1 reference

IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

21 January 2018

1 reference

Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients.

21 January 2018

1 reference

Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis

21 January 2018

1 reference

T helper 17 polarization in familial Mediterranean fever

21 January 2018

1 reference

Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis

21 January 2018

1 reference

Alternative activation in systemic juvenile idiopathic arthritis monocytes

21 January 2018

1 reference

Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome

21 January 2018

1 reference

Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis

21 January 2018

1 reference

Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.

21 January 2018

1 reference

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome

21 January 2018

1 reference

Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis

21 January 2018

1 reference

Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment

21 January 2018

1 reference

Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice

21 January 2018

1 reference

Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.38615

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

94926

OpenCitations bibliographic resource ID

94926

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

94926

PubMed publication ID

24623686

1 reference